CDC Logo Tuberculosis Information CD-ROM   Image of people
     
jump over main navigation bar to content area
Home
TB Guidelines
Surveillance Reports
Slide Sets
TB-Related MMWRs and Reports
Education/Training Materials
Newsletters
Ordering Information
Help

 

U.S. Department of Health and Human Services

  

TB Notes Newsletter

No. 2, 2005

NEW CDC PUBLICATIONS

Bozeman L, Burman W, Metchock B, Welch L, and Weiner M. Fluoroquinolone susceptibility among Mycobacterium tuberculosis isolates from the United States and Canada. Clinical Infectious Diseases 2005 Feb 1; 40 (3): 386-91.

Burgos M, Gonzalez LC, Paz EA, Gournis E, Kawamura LM, Schecter G, Hopewell PC, and Daley CL. Treatment of multidrug-resistant tuberculosis in San Francisco: an outpatient-based approach. Clinical Infectious Diseases 2005 Apr 1;40(7): 968-75.

CDC. Congenital Pulmonary Tuberculosis Associated with Maternal Cerebral Tuberculosis --- Florida, 2002. MMWR 2005 Mar 18; 54(10): 249-250.

CDC. National plan for reliable laboratory services using a systems approach: recommendations from CDC and the Association of Public Health Laboratories Task Force on Tuberculosis Laboratory Services. MMWR 2005; 54(No. RR-6).

CDC. Notice to Readers: New CDC Program for Rapid Genotyping of Mycobacterium tuberculosis Isolates. MMWR 2005 Jan 21; 54(2): 47.

CDC. Trends in Tuberculosis --- United States, 2004. MMWR 2005 Mar 18; 54(10): 245-249.

CDC. Tuberculosis Transmission in a Homeless Shelter Population --- New York, 2000—2003. MMWR 2005 Feb 18; 54(6): 149-152.

CDC. World TB Day --- March 24, 2005. MMWR 2005 Mar 18; 54(10): 245.

Cowan LS, Diem L, Monson T, Wand P, Temporado D, Oemig TV, and Crawford JT. Evaluation of a two-step approach for large-scale, prospective genotyping of Mycobacterium tuberculosis isolates in the United States. Journal of Clinical Microbiology 2005 Feb; 43 (2): 688-95.

Dewan P, Sosnovskaja A, Thomsen V, Cicenaite J, Laserson K, Johansen I, Davidaviciene E, and Wells C. High prevalence of drug-resistant tuberculosis, Republic of Lithuania, 2002. International Journal of Tuberculosis and Lung Disease 2005 Feb; 9 (2): 170-4.

Frieden TR and Munsiff SS. The DOTS strategy for controlling the global tuberculosis epidemic. Clinics in Chest Medicine 2005 Jun; 26(2): 197-205.

Haddad MB, Wilson TW, Ijaz K, Marks SM, Moore M. Tuberculosis and homelessness in the United States, 1994–2003. JAMA 2005; 293(22): 2762-2766.

Hadzibegovic DS, Maloney SA, Cookson ST, and Oladele A. Determining TB rates and TB case burden for refugees. International Journal of Tuberculosis and Lung Disease 2005 Apr; 9(4): 409-14.

Jasmer RM, Bozeman L, Schwartzman K, Cave MD, Saukkonen JJ, Metchock B, Khan A, Burman WJ. Recurrent tuberculosis in the United States and Canada: relapse or reinfection? American Journal of Respiratory and Critical Care Medicine 2004 Dec 15; 170 (12): 1360-6.

Jasmer RM, Seaman CB, Gonzalez LC, Kawamura LM, Osmond DH, Daley CL. Tuberculosis treatment outcomes: directly observed therapy compared with self-administered therapy. American Journal of Respiratory and Critical Care Medicine 2004 Sep 1; 170 (5): 561-6.

Kammerer JS, McNabb SJ, Becerra JE, Rosenblum L, Shang N, Iademarco MF, and Navin TR. Tuberculosis transmission in nontraditional settings: a decision-tree approach. American Journal of Preventive Medicine 2005 Feb; 28 (2): 201-7.

Laserson KF, Thorpe LE, Leimane V, Weyer K, Mitnick CD, Riekstina V, Zarovska E, Rich ML, Fraser HSF, Alarcón, Cegielski JP, Grzemska M, Gupta R, Espinal M. Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. International Journal of Tuberculosis and Lung Disease 2005; 9(6): 640-645.

Lobato MN, Reves RR, Jasmer RM, Grabau JC, Bock NN, Shang N (2RZ Study Group). Adverse events and treatment completion for latent tuberculosis in jail inmates and homeless persons. Chest 2005; 127(4): 1296-1303.

LoBue PA and Moser KS. Isoniazid- and rifampin-resistant tuberculosis in San Diego County, California, United States, 1993-2002. International Journal of Tuberculosis and Lung Disease 2005 May; 9(5): 501-6.

LoBue PA and Moser KS. Treatment of Mycobacterium bovis–infected tuberculosis patients: San Diego County, California, United States, 1994-2003. International Journal of Tuberculosis and Lung Disease 2005 Mar; 9 (3): 333-8.

Martinez A, Balandrano S, Parissi A, Zuniga A, Sanchez M, Ridderhof J, Lipman HB, and Madison B. Evaluation of new external quality assessment guidelines involving random blinded rechecking of acid-fast bacilli smears in a pilot project setting in Mexico. International Journal of Tuberculosis and Lung Disease 2005 Mar;9(3): 301-5.

Santha T, Garg R, Subramani R, Chandrasekaran V, Selvakumar N, Sisodia RS, Perumal M, Sinha SK, Singh RJ, Chavan R, Ali F, Sarma SK, Sharma KM, Jagtap RD, Frieden TR, Fabio L, and Narayanan PR. Comparison of cough of 2 and 3 weeks to improve detection of smear-positive tuberculosis cases among out-patients in India. International Journal of Tuberculosis and Lung Disease 2005 Jan; 9 (1): 61-8.

Schneider E. Tuberculosis Among American Indians and Alaska Natives in the United States, 1993-2002. American Journal of Public Health 2005; 95(5): 873-880.

Schneider E, Moore M, and Castro KG. Epidemiology of tuberculosis in the United StatesClinics in Chest Medicine 2005 Jun;26(2): 183-195.

Selvakumar N, Sivagamasundari S, Prabhakaran E, Govindaraju R, Perumal M, Granich R, Wares F, Chauhan LS, and Narayanan PR. Storage of heat-fixed unstained sputum AFB smears for panel testing in a tuberculosis unit in South India. International Journal of Tuberculosis and Lung Disease 2005 Feb; 9 (2): 223-5.

Weiner M, Benator D, Burman W, Peloquin CA, Khan A, Vernon A, Jones B, Silva-Trigo C, Zhao Z, and Hodge T. Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis. Clinical Infectious Diseases 2005 May 15;40(10): 1481-91.

 


Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination - http://www.cdc.gov/tb

Please send comments/suggestions/requests to: hsttbwebteam@cdc.gov, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333